Surgical
Innovations Group plc
("Surgical Innovations", the "Company", or the
"Group")
Notice of Annual General
Meeting
Posting of 2023 Annual Report
& Accounts
Surgical Innovations Group Plc (AIM:
SUN), the designer, manufacturer and distributor of innovative
technology for minimally invasive surgery, confirms that the Annual
Report and Accounts for the year ended 31 December 2023 ("2023
Annual Report") and the Notice of the 2024 Annual General Meeting
("AGM") have now been published and can be accessed via the
"Investor Centre" section of the Company's website
at: www.sigroupplc.com.
The 2023 Annual Report, the Notice
of AGM and details of voting by proxy have been posted to
shareholders who have not consented to receive electronic
communications.
Notice of AGM
The AGM is to be held on Monday 17
June 2024 at 11:00 am at the Company's offices at Clayton Wood
House, 6 Clayton Wood Bank, Leeds, LS16 6QZ and will consider the
Resolutions set out in the Notice of AGM.
The Company will broadcast its AGM
on the Investor Meeting Company ("IMC") platform and there will be
an opportunity for investors to ask questions after the formal
business of the meeting concludes. Questions can also be pre
submitted via the IMC platform up until 16 June 2024 at 09:00 am or
submitted at any time during the AGM itself. Investors can sign up
to IMC for free and add to meet Surgical Innovations Group plc
via:
https://www.investormeetcompany.com/surgical-innovations-group-plc/register-investor
Shareholders taking part via the IMC platform will not be able
to speak or vote on the AGM resolutions. Shareholders are therefore strongly encouraged to exercise
their voting rights by completing and submitting a Form of Proxy.
It is highly recommended that Shareholders submit their Form of
Proxy as early as possible to ensure that their votes are counted
at the AGM. Shareholders are strongly encouraged to appoint the
Chairman as your proxy to ensure that each shareholder's vote will
be counted in the event of restrictions on shareholders and proxies
attending the AGM in person.
If you wish to attend the AGM in
person and in your capacity as a shareholder wish to vote on the
day, please bring proof of shareholding or if shares are held
through a nominee account, a letter of representation, to
facilitate your voting rights.
For further information please contact:
|
Surgical Innovations Group plc
|
www sigroupplc
com
|
|
David Marsh, CEO
|
Tel: 0113
230 7597
|
|
|
|
|
Singer Capital Markets (Nominated
Adviser & Broker)
|
Tel: 020
7496 3000
|
|
Aubrey Powell / Oliver
Platts
|
|
|
|
|
|
Walbrook PR
(Financial PR & Investor Relations)
|
Tel: 020
7933 8780 or si@walbrookpr.com
|
|
Paul
McManus / Charlotte Edgar
|
Mob: 07980
541 893 / 07884 664 686
|
|
|
| |
About Surgical Innovations Group
plc
The Group specialises in the design,
manufacture, sale and distribution of innovative, high quality
medical products, primarily for use in minimally invasive surgery.
Our product and business development is guided and supported by a
key group of nationally and internationally renowned surgeons
across the spectrum of minimally invasive surgical
activity.
We design and manufacture and source
our branded port access systems, surgical instruments and
retraction devices which are sold directly in the UK home market
through our subsidiary, Elemental Healthcare, and exported widely
through a global network of trusted distribution partners. Many of
our products in this field are based on a "resposable" concept, in
which the products are part reusable, part disposable, offering a
high quality and environmentally responsible solution at a cost
that is competitive against fully disposable
alternatives.
Elemental also has exclusive UK
distribution for a select group of specialist products employed in
laparoscopy, bariatric and metabolic surgery, hernia repair and
breast reconstruction.
In addition, we design and develop
medical devices for carefully selected OEM partners and have also
collaborated with a major UK industrial partner to provide
precision engineering solutions to complex problems outside the
medical arena.
We aim for our brands to be
recognised and respected by healthcare professionals in all major
geographical markets in which we operate and provide by
development, partnership or acquisition a broad portfolio of cost
effective, procedure specific surgical instruments and implantable
devices that offer reliable solutions to genuine clinical needs in
the operating theatre environment.
Further information
Further details of the Group's
businesses and products are available on the following
websites:
www.sigroupplc.com
www.surginno.com
www.elementalhealthcare.co.uk
To receive regular updates by email,
please contact si@walbrookpr.com